All Journals

Bridges procedural skin science and medical dermatology, publishing rigorous original work that advances research, education and evidence-based practice for dermatologists, aesthetic physicians, cosmetic scientists and skin researchers worldwide. The journal's core remit spans regenerative and aesthetic dermatology, including collagen biostimulators (poly-L-lactic acid, calcium hydroxyapatite, polycaprolactone), hyaluronic acid dermal fillers, platelet-rich plasma, lipofilling and cellular therapies for facial rejuvenation. It equally welcomes laser and energy-based procedures, melasma and pigmentary disorders, skin ageing, barrier function and cosmeceuticals such as ceramide-based moisturizers, alongside medical dermatology topics including atopic dermatitis, cutaneous infections and hair and scalp disorders. We consider original research, systematic and narrative reviews, clinical and case reports, and editorials addressing clinical, translational and methodological questions in dermatological science. Every submission undergoes double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright, assigned a permanent Crossref DOI, and made discoverable through OpenAlex, Google Scholar and an OAI-PMH endpoint. The journal follows COPE ethical principles to safeguard integrity and the scholarly record.

Disseminates rigorous, original scholarship across the full spectrum of diabetology, from the molecular pathophysiology of type 2 diabetes mellitus, insulin resistance and beta-cell dysfunction to the clinical management of glycemic control, diabetic complications and metabolic disease. The journal welcomes work on prediabetes and incident diabetes, risk-factor epidemiology, diabetes prevention and screening, oral hypoglycemic agents and GLP-1 receptor agonists, diabetic nephropathy and chronic kidney disease, genome-wide association and polygenic studies, drug utilization evaluation, and health-related quality of life. We publish original research, systematic and narrative reviews, clinical case reports, and editorials that bridge bench, bedside and population health. JODR serves endocrinologists, diabetologists, nephrologists, clinical researchers, public-health scientists, pharmacologists and trainees seeking a trusted, internationally accessible venue. Every submission undergoes double-blind peer review by subject experts. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright, assigned a permanent Crossref DOI, indexed for discovery via OpenAlex and Google Scholar, and exposed through an OAI-PMH endpoint for harvesting. The journal follows COPE ethical principles, and article-processing charges apply on acceptance with waivers and discounts available.

Dedicated to the full spectrum of reconstructive, aesthetic, microsurgical and regenerative surgery. The journal publishes rigorous original research, systematic reviews, technique articles, case reports and editorials that advance clinical practice and translational science across the discipline. The scope spans breast reconstruction and free-flap surgery (including DIEP flaps, microsurgical anastomosis, free-flap monitoring and drain management), craniofacial, maxillofacial and orthognathic surgery, hand surgery and replantation, burn and wound reconstruction, cutaneous tumor and skin lesion management, and aesthetic surgery. We particularly welcome work on regenerative techniques such as adipose-derived mesenchymal stem cells, fat grafting, biomaterials and targeted drug delivery, alongside studies of patient-reported outcomes, quality of life and psychosocial impact. Intended for plastic and reconstructive surgeons, microsurgeons, surgical trainees, and translational researchers, the journal connects bench and bedside through an internationally accessible platform. Every submission undergoes double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright, assigned a permanent Crossref DOI, and made discoverable through OpenAlex, Google Scholar and an OAI-PMH endpoint. Editorial practice follows COPE principles.

Disseminates rigorous, original scholarship across musculoskeletal, neurological, cardiorespiratory and sports physiotherapy, advancing evidence-based practice for clinicians, researchers, educators and students in physical therapy and rehabilitation science worldwide. The journal welcomes original research articles, randomised controlled trials, systematic reviews and meta-analyses, clinical case reports, technical notes and editorials. Core topics include therapeutic and exercise therapy, manual therapy, low back and neck pain management, post-surgical and orthopaedic rehabilitation, neurological rehabilitation after stroke and spinal cord injury, pain science, posture and movement, telerehabilitation, and validated outcome measures such as disability indices and pressure pain thresholds. JOPTR serves physiotherapists, rehabilitation scientists, exercise physiologists and allied health professionals seeking robust, reproducible findings that bridge laboratory, clinic and community settings. Methodologically diverse quantitative and qualitative work is encouraged, with transparent reporting and clinically meaningful outcomes prioritised. Every submission undergoes double-blind peer review. Accepted articles are published under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright, assigned a permanent Crossref DOI, and made discoverable through OpenAlex, Google Scholar and an OAI-PMH endpoint. The journal follows COPE ethical principles.

Advances scholarship across epidemiology, infectious disease and immunization, health policy and systems, environmental and occupational health, and maternal, child and behavioral health, serving researchers, clinicians, epidemiologists, and policymakers worldwide. TAJOPH publishes original research, systematic and narrative reviews, case reports, short communications, and editorials. We particularly welcome work on disease surveillance, vaccine confidence and immunization, antimicrobial resistance, non-communicable disease prevention, social determinants of health, and the population-level lessons of COVID-19 and other public health emergencies. Emphasis is placed on methodological rigor and translational relevance, from quantitative epidemiology and risk-prediction modeling to qualitative and health-systems research that informs policy and practice across high-, middle-, and low-resource settings. Every submission undergoes double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) license with authors retaining copyright, are assigned a permanent Crossref DOI, and are made discoverable through OpenAlex, Google Scholar, and an OAI-PMH endpoint. The journal follows COPE ethical principles, with article-processing charges applied on acceptance and waivers available.

Disseminates rigorous, clinically relevant scholarship spanning maternal-fetal medicine, gynecologic oncology, urogynecology and pelvic floor disorders, reproductive endocrinology, contraception, and obstetric and gynecologic surgery, connecting clinicians, researchers, and trainees on an internationally accessible platform. The journal welcomes original research, systematic reviews, narrative reviews, case reports, and editorials on high-risk pregnancy, preeclampsia and hypertensive disorders, gestational diabetes mellitus, fetal growth restriction, obstetric critical care, postpartum hemorrhage, endometrial and cervical disease, pelvic organ prolapse, urinary incontinence, obstetric fistula, and family planning. We value robust study design, biomarker and risk-prediction work, and translational findings that improve maternal and women's health outcomes. Every submission undergoes double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright, and each receives a permanent Crossref DOI for citability and long-term preservation. Content is discoverable through OpenAlex and Google Scholar and exposed via an OAI-PMH endpoint for harvesting. Directive Publications follows COPE ethical principles. An article-processing charge applies on acceptance, with waivers and discounts available to support equitable participation. Researchers and clinicians worldwide are invited to read JOCOGR and to submit their manuscripts.

Advances evidence on the prevention, diagnosis, and management of disease across the pediatric age range, from the neonate in the NICU to the adolescent, and serves as a discoverable, internationally accessible record of clinical pediatric scholarship. We publish original research, clinical case reports and case series, systematic and narrative reviews, and editorials spanning neonatology and neonatal intensive care, general and community pediatrics, pediatric rheumatology and autoimmunity (including juvenile idiopathic arthritis), pediatric oncology and hematology, pediatric infectious disease and vaccination, and pediatric surgery and orthopedics. Topics include neonatal pain management, post-COVID syndrome in children, rare pediatric syndromes, childhood cancer outcomes, and parental knowledge and behavior. Manuscripts are evaluated through double-blind peer review against COPE ethical principles. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright, and each receives a permanent Crossref DOI. Content is indexed by OpenAlex and Google Scholar and exposed through an OAI-PMH endpoint for harvesting, maximizing citability and long-term discoverability. Clinicians and investigators are invited to read current pediatric research and to submit manuscripts that improve the care and health of infants, children, and adolescents worldwide.

Advances the science and practice of clinical and medical microbiology. The journal serves microbiologists, infectious disease clinicians, laboratory scientists and public health researchers with rigorous, original scholarship that bridges the diagnostic laboratory and the bedside. We welcome original research, reviews, case reports and editorials across antimicrobial resistance (AMR) and antimicrobial stewardship, diagnostic and molecular microbiology, antimicrobial susceptibility testing, bacterial, viral, fungal and parasitic infections, healthcare-associated infections, bloodstream infections, tuberculosis, and emerging and zoonotic pathogens. Studies applying One Health, genomics, next-generation sequencing and surveillance methods are particularly encouraged. Every submission undergoes double-blind peer review in line with COPE ethical principles. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, with authors retaining copyright, and each receives a permanent Crossref DOI. Content is discoverable through Google Scholar and OpenAlex and harvestable via our OAI-PMH endpoint, ensuring citability and long-term availability for a global readership of researchers and practitioners.

Dedicated to original research that translates fundamental science into practical impact. As a multidisciplinary applied sciences journal, JOAS publishes work spanning applied physics, applied chemistry, materials and nanoscience, applied biology and life sciences, environmental and ecological science, and applied data and social science. The journal exists to connect investigators, engineers, and practitioners worldwide through a trusted and openly citable platform. JOAS welcomes original research articles, critical reviews, case reports, methodological notes, and editorials. Topics of interest include nanomaterials and energy materials such as dye-sensitised solar cells and polymer electrolytes; proteomics, immunomodulation, and biomarker studies; biodiversity, coral-reef health, soil and root-system science; instrumentation and measurement methods including SEM-EDX, X-ray diffraction, and neutron-activation standardisation; food authentication and aroma science; and applied statistical analysis of socio-economic problems such as multidimensional poverty. Every manuscript undergoes rigorous double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, with authors retaining copyright, and are assigned a permanent Crossref DOI. Content is discoverable through OpenAlex and Google Scholar and exposed for harvesting via an OAI-PMH endpoint. JOAS follows COPE ethical principles and offers article-processing-charge waivers and discounts to widen participation, particularly for early-career and lower-income-country authors.

Disseminates original scholarship on robot-assisted and minimally invasive surgery across the surgical specialties, serving surgeons, surgical trainees, biomedical engineers, and clinical researchers who advance the science and practice of surgical robotics. The journal covers the full arc of robotic surgery: robotic urologic surgery (including single-port and radical prostatectomy), robotic general and gastrointestinal surgery (such as distal pancreatectomy and colorectal procedures), pediatric robotic surgery (including pyeloplasty), robotic thoracic surgery, and gynecologic and hepatobiliary applications. We also welcome work on robotic platforms and the da Vinci surgical system, learning curves, operative-time and outcomes analyses, cost-effectiveness, simulation and training, and comparative laparoscopic-versus-robotic studies. We publish original research, systematic reviews, technical notes, case reports, case series, and editorials addressing the methodological, translational, and applied dimensions of the field. Every submission undergoes double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright, assigned a permanent Crossref DOI, and made discoverable through OpenAlex, Google Scholar, and an OAI-PMH endpoint. The journal follows COPE ethical principles, ensuring a citable and openly accessible scholarly record.

Dedicated to the molecular, cellular, clinical and computational study of the immune system. It publishes original research, reviews, case reports and editorials spanning innate and adaptive immunity, autoimmunity and autoantibodies, tumor immunology and immunotherapy, infection and host defense, and the cytokine and chemokine networks that coordinate immune responses. The journal welcomes work on immune cell biology, neutrophil extracellular traps, antibody and receptor signaling, vaccine immunology, and inflammation, as well as studies in viral infection (including SARS-CoV-2 and post-COVID immunopathology), tuberculosis, and hepatitis. We encourage translational and methodological contributions, including immunology bioinformatics, Mendelian randomization of immune cell traits, and biomarker discovery using clinical and laboratory data. Intended for immunologists, clinician-scientists, oncologists, infectious-disease researchers and laboratory investigators worldwide, the journal bridges bench and bedside. Every submission undergoes double-blind peer review; accepted articles are published under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright, assigned a permanent Crossref DOI, and made discoverable through OpenAlex, Google Scholar and an OAI-PMH endpoint. Editorial practice follows COPE principles.

Serves pathologists, laboratory scientists, clinical chemists, microbiologists and translational researchers seeking a rigorous, discoverable venue for diagnostic work that informs patient care. The journal covers the diagnostic spectrum: histopathology and surgical pathology, cytopathology and fine-needle aspiration cytology, immunohistochemistry (markers such as Her2/neu), haematopathology, clinical chemistry and biomarker studies (HbA1c, ferritin, D-dimer), and molecular and infectious-disease diagnostics using qPCR and FFPE methods. We welcome original research, reviews, diagnostic case reports, method-validation studies and editorials. Every submission undergoes double-blind peer review following COPE principles. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, authors retain copyright, and each receives a permanent Crossref DOI, discoverable through OpenAlex and Google Scholar and exposed via OAI-PMH.

Dedicated to disseminating rigorous research across the breadth of internal medicine and clinical practice. The journal serves clinicians, clinician-scientists, residents and translational researchers seeking a trusted, internationally discoverable venue for evidence-based work that informs diagnosis, treatment and patient outcomes. We welcome original research, systematic and narrative reviews, clinical case reports and case series, and editorials spanning nephrology and transplant medicine, cardiovascular disease, infectious disease and immunology, oncology, gastroenterology, autoimmune and multisystem disorders. Coverage extends to clinical methodology, real-world evidence, and the diagnostic and therapeutic challenges encountered in everyday practice. Every submission undergoes double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, with authors retaining copyright, and are assigned a permanent Crossref DOI. Content is indexed by OpenAlex and Google Scholar and exposed through an OAI-PMH endpoint for harvesting. The journal follows COPE ethical principles and is committed to transparency and integrity. An article-processing charge applies on acceptance, with waivers and discounts available to ensure equitable access to publication.

Advances scholarship across the breadth of the discipline and its subspecialties, including cardiometabolic medicine, nephrology, infectious and post-viral disease, geriatric medicine and frailty, and hospital and perioperative care. We publish original clinical and translational research, narrative and systematic reviews, clinical case reports and case series, and editorials that improve diagnosis, evidence-based management, and patient outcomes. Recent topics span long COVID and the gut-brain axis, frailty assessment in older adults, chronic renal disease, atherosclerosis and vascular inflammation, and postoperative outcomes after surgery. Every submission undergoes rigorous double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright, and each receives a permanent Crossref DOI. Content is discoverable through OpenAlex and Google Scholar and is openly harvestable via our OAI-PMH endpoint. The journal follows COPE ethical principles and serves a global readership of internists, primary care physicians, trainees, and biomedical researchers seeking trustworthy, openly accessible internal medicine research.

Publishes original research, reviews, and case reports spanning the diagnosis, mechanisms, and management of endocrine and metabolic disease, with a translational emphasis that connects laboratory discovery to bedside practice for clinicians, endocrinologists, and biomedical researchers. Core coverage includes diabetes mellitus and incretin-based therapeutics (GLP-1 receptor agonists, tirzepatide, semaglutide), obesity and metabolic syndrome, and lipid and lipoprotein disorders such as dysbetalipoproteinemia. The journal has notable depth in adrenal disease and steroidogenesis, including congenital adrenal hyperplasia, primary adrenal insufficiency, and HPA-axis and cortisol dysregulation, alongside thyroid, pituitary, and reproductive endocrinology. We welcome studies using clinical trials, observational cohorts, endocrine diagnostics (immunoassays, imaging, ultrasonography), and emerging methods such as single-cell sequencing. Submissions are evaluated by rigorous double-blind peer review. Accepted articles are published open access under a Creative Commons CC-BY 4.0 licence with authors retaining copyright, assigned a permanent Crossref DOI, and made discoverable through OpenAlex, Google Scholar, and an OAI-PMH endpoint. The journal follows COPE ethical principles.

Advances research across the full spectrum of autoimmunity and clinical immunology. The journal disseminates original scholarship on the breakdown of immune self-tolerance and the resulting systemic and organ-specific autoimmune diseases, serving immunologists, rheumatologists, clinical investigators, and translational scientists worldwide. We welcome work on systemic autoimmune rheumatic conditions such as systemic lupus erythematosus, rheumatoid arthritis, and Sjogren's syndrome, alongside organ-specific disorders including autoimmune thyroiditis, vitiligo, coeliac disease, and autoimmune skin disease. Mechanistic studies of epitope spreading, autoantibodies, innate and adaptive immunity, and molecular mimicry are central to our remit, as are investigations of environmental and infectious triggers, including COVID-19, Helicobacter pylori, and drug-induced autoimmunity. The journal also prioritizes diagnosis, classification, biomarkers, epidemiology, and therapeutics, from validation of SLICC and EULAR/ACR criteria to biologic and TNF-inhibitor strategies. We publish original research, systematic reviews, case reports, and editorials. Every submission undergoes double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright, receive a permanent Crossref DOI, and are made discoverable through OpenAlex, Google Scholar, and an OAI-PMH endpoint, in line with COPE ethical principles.

Advancing the science and clinical practice of infectious diseases. It publishes original research across infectious disease epidemiology, antimicrobial resistance and stewardship, emerging and re-emerging infections, tropical and neglected diseases, and healthcare-associated infections, serving clinicians, microbiologists, epidemiologists, and public health researchers worldwide. We welcome work across the spectrum of pathogens, including viral infections such as HIV/AIDS, hepatitis B, dengue, and Lassa fever; bacterial and fungal infections including sporotrichosis, leptospirosis, and scrub typhus; vaccine and immunization research; and clinical syndromes such as catheter-related bloodstream and post-surgical urinary tract infections. Studies on surveillance, diagnostics, antibiotic utilization (including WHO AWaRe classification), and One Health are especially encouraged. JOID accepts original research, systematic and narrative reviews, case reports, and editorials. Every submission undergoes double-blind peer review consistent with COPE principles. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, with authors retaining copyright, and each receives a permanent Crossref DOI. Content is discoverable via OpenAlex and Google Scholar and harvestable through our OAI-PMH endpoint.

Dedicated to advancing clinical and translational research across the musculoskeletal system. The journal disseminates rigorous original scholarship spanning orthopedic surgery, arthroplasty, sports medicine, orthopedic trauma, spine, and the biomechanics of bone, joint, tendon, and ligament, connecting surgeons, researchers, and allied practitioners through a trusted international platform. We welcome original research, systematic reviews, clinical and surgical outcome studies, case reports, technical notes, and editorials. Core topics include total knee and hip arthroplasty, ankle and ligament reconstruction, platelet-rich plasma and regenerative therapies, fracture fixation and trauma management, 3D-printed and patient-specific implants, computer-assisted navigation, gait and motion analysis, and the management of musculoskeletal tumors and degenerative disorders. Every submission undergoes double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, with authors retaining copyright, and each receives a permanent Crossref DOI. Content is discoverable through OpenAlex and Google Scholar and harvestable via our OAI-PMH endpoint, ensuring citability, reach, and long-term preservation of the orthopedic record. The journal serves orthopedic surgeons, sports-medicine physicians, biomechanists, physiotherapists, and musculoskeletal researchers worldwide. An article-processing charge applies on acceptance, with waivers and discounts available, and the journal follows COPE ethical principles throughout editorial decision-making.

Devoted to the science and clinical practice of rheumatology and musculoskeletal medicine. As an arthritis and rheumatology journal, it disseminates rigorous original research on rheumatoid arthritis, systemic lupus erythematosus, axial spondyloarthritis and ankylosing spondylitis, osteoarthritis, gout and crystal arthropathies, vasculitis, and other autoimmune and connective tissue diseases. The journal welcomes original research, systematic reviews, clinical trials, case reports, and editorials spanning pathophysiology, epidemiology, imaging and biomarkers, and therapeutics. Topics of particular interest include disease-modifying antirheumatic drugs and biologic therapy, early detection of inflammatory arthritis, advanced imaging such as PET-CT and musculoskeletal ultrasound, and joint-preserving and arthroplasty outcomes. Intended for rheumatologists, immunologists, orthopaedic and musculoskeletal researchers, and allied health professionals, the journal connects investigators and clinicians through a trusted, internationally accessible platform. Every submission undergoes double-blind peer review; accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright, assigned a permanent Crossref DOI, and made discoverable through OpenAlex, Google Scholar, and an OAI-PMH endpoint. The journal follows COPE ethical principles.

Advances research, education and clinical practice on the diseases and health challenges of tropical and subtropical regions, with a strong focus on neglected tropical diseases (NTDs), malaria and vector-borne illness, tropical infectious diseases, antimicrobial resistance, and public health and nutrition in low- and middle-income settings. We publish original research, systematic and narrative reviews, case reports and case series, short communications and editorials spanning clinical tropical medicine, parasitology and entomology, bacteriology, mycology and virology, infectious-disease epidemiology, One Health approaches to antimicrobial resistance, and outbreak and elimination science. Topics range from malaria burden and schistosomiasis to HIV-associated opportunistic infections, COVID-19 endemic transition, antibiotic residues in hospital wastewater, and child malnutrition across Africa. Every submission undergoes rigorous double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, with authors retaining copyright, and receive a permanent Crossref DOI. Content is discoverable through OpenAlex and Google Scholar and is openly harvestable via our OAI-PMH endpoint. ATM follows COPE ethical principles and especially welcomes evidence-based work from researchers and clinicians in endemic regions, offering article-processing-charge waivers and discounts to support global, equitable participation in the scholarly record.

Disseminates original research, reviews, case studies, and short communications across the environmental sciences, with emphasis on environmental pollution and control, wastewater and nutrient treatment, air quality, climate change, greenhouse-gas and carbon accounting, renewable energy, and sustainability. The journal welcomes work spanning environmental monitoring and remote sensing (drought indices such as VCI and VHI, satellite rainfall products, and LiDAR-based biomass and carbon-stock estimation), water and soil conservation, ecology and biodiversity, circular-economy waste management, and environmental nanomaterials and toxicity. We value rigorous field, laboratory, modeling, and policy-analysis methods that advance both fundamental understanding and applied environmental management. JOES serves environmental scientists, engineers, ecologists, policy analysts, and practitioners worldwide. Every submission undergoes double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, with authors retaining copyright, and each is assigned a permanent Crossref DOI. All content is discoverable through OpenAlex and Google Scholar and is exposed via an OAI-PMH endpoint for harvesting. The journal follows COPE ethical principles, and an article-processing charge applies on acceptance, with waivers and discounts available for eligible authors.

Advances clinical and translational scholarship across the breadth of oral health science, serving dentists, oral and maxillofacial surgeons, periodontists, endodontists, prosthodontists, pediatric and public-health dental clinicians, and biomedical researchers worldwide. The journal welcomes original research, clinical trials, in vitro and laboratory studies, systematic reviews, narrative reviews, case reports, and short communications. Core areas include implant dentistry and osseointegration (implant stability, osseodensification, alveolar ridge preservation, abutment design), oral and maxillofacial surgery and tissue regeneration (platelet-rich fibrin, bone regeneration, sinus anatomy), restorative dentistry, endodontics and dental pulp biology (odontogenic differentiation, biomaterials, dental erosion), and pediatric and preventive dentistry (silver diamine fluoride, caries control, oral health education). JODOR also features emerging themes in digital and public-health dentistry, including artificial intelligence in dental education, genomic dentistry, oral health epidemiology, and access to care. The journal emphasizes methodological rigor, biocompatibility, and clinical effectiveness. Every submission undergoes double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, with authors retaining copyright, and each receives a permanent Crossref DOI. Content is discoverable via OpenAlex and Google Scholar and harvestable through OAI-PMH, and the journal follows COPE ethical principles.

Advances the scientific understanding, prevention, and treatment of mental disorders, publishing rigorous original work across clinical psychiatry, biological and neuropsychiatry, psychopharmacology, and mental health services research that informs both bench investigators and frontline clinicians. The journal welcomes original research, systematic reviews, meta-analyses, case reports, and editorials on mood and anxiety disorders, depression, post-traumatic stress disorder, obsessive-compulsive disorder, autism spectrum and neurodevelopmental conditions, addiction and substance use disorders, forensic psychiatry, and the social determinants of mental health, including stigma and discrimination. Emerging therapeutics such as psychedelic-assisted psychotherapy and novel psychopharmacological agents are within scope. We value methodological transparency across epidemiological, clinical-trial, translational, and qualitative designs, and encourage studies addressing under-served populations and global mental health. Every submission undergoes double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright, receive a permanent Crossref DOI, and are made discoverable through OpenAlex, Google Scholar, and an OAI-PMH endpoint. The journal follows COPE ethical principles.

Advances translational, molecular, and clinical biomedical research. Spanning the full breadth of the biomedical sciences, the journal connects laboratory discovery with patient-centred application across investigators, clinicians, and educators worldwide. The journal welcomes original research, reviews, case reports, and editorials in molecular and cellular biomedicine (including noncoding RNA, tRNA- and snoRNA-derived fragments, RNA processing, and sirtuins), cardiovascular biomedicine (cardiac remodeling, myocardial infarction, and coronary artery disease), immunology and autoimmune disease (Th17/Treg balance, systemic sclerosis, and immunomodulation), drug delivery and nanomedicine (biomimetic and nanoparticle-based therapies), and pharmacology and therapeutics. Methodological, translational, and public-health dimensions of these fields are all in scope. Every submission undergoes rigorous double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, with authors retaining copyright, and are assigned a permanent Crossref DOI to ensure citability and long-term preservation. Content is discoverable through OpenAlex, Google Scholar, and an OAI-PMH endpoint for harvesting, and the journal follows COPE ethical principles. An article-processing charge applies on acceptance, with waivers and discounts available to support equitable participation.